Skip to main content
Press Enter
Home page
Care Creations logo
URL Successfully Copied!

You can now paste the url to easily share it

Getty Images 813786168 Crop 2

Flavagrum PEG A00245

INCI: PEG-6 Isostearate (and) Hesperetin Laurate

A Powerful tissue draining flavonoid, visibly and intensely diminishing under eye puffiness, 3 hours after the application. Free radical protection against UV induced protein peroxidation. Protection of elastic fibers from enzymatic degradation.

How FlavagrumPEG reduces under-eye puffiness

Flavagrum™ PEG is stabilized hesperetin from soft orange tissue that is draining and protective. It is a hesperetin that is stabilized using a patented technique that combines fatty acid chains. Hesperetin is a powerful tissue draining flavonoid.

The unique nature of this approach

This technique ensures that the molecule remains perfectly stable, both in terms of color and activity.

The benefits for the consumer and formulator

We have proven that Flavagrum™ PEG visibly and intensely diminishes under eye puffiness, 3 hours after the application of a formula that contains 3% of the active ingredient (in vivo data). Flavagrum™ PEG offers powerful anti-free radical protection against UV induced protein peroxidation, even in very low concentrations (0.1%) (in vitro data). It also protects the elastic fibers from enzymatic degradation (in vitro data ).

It may be used in all formulas without additional coloring because it is controlled thanks to its patented , stabilization technique.

Login to Request a Sample or View Full Details & Resources


Skin Care
Eye treatment
Face Care

Although all statements and information in this publication are believed to be accurate and reliable, they are presented gratis and for guidance only, and the risks and liability for results obtained by use of the products or application of the suggestions described are assumed by the user. THERE ARE NO WARRANTIES OF ANY KIND. ALL EXPRESS AND IMPLIED WARRANTIES ARE DISCLAIMED. The user should not assume that toxicity data and safety measures are indicated or that other measures may not be required. The claims and supporting data provided in this publication have not been evaluated for compliance with any jurisdiction’s regulatory requirements and the results reported may not be generally true under other conditions or in other matrices. Users must evaluate what claims and information are appropriate and comply with a jurisdiction’s regulatory